Disopyramide Phosphate
Disopyramide Phosphate comes in 9 pill versions in our database, in 3 strengths, from 4 manufacturers. Check the imprint to tell them apart.
Disopyramide Phosphate pill images
100 mg 4 pills
-
93 3127 93 3127
Disopyramide Phosphate 100 mg
Blue & red, capsule, 19 mm
Used for atrial fibrillation (irregular heartbeat) and atrial flutter
- SEARLE 2732 NORPACE CR 100 MG Disopyramide Phosphate 100 mg Green & white, capsule, 18 mm Used for atrial fibrillation (irregular heartbeat) and atrial flutter
- m 095 Disopyramide Phosphate 100 mg Orange, capsule, 19 mm Used for atrial fibrillation (irregular heartbeat) and atrial flutter
- SEARLE 2752 NORPACE 100 MG Disopyramide Phosphate 100 mg Orange & white, capsule, 19 mm Used for atrial fibrillation (irregular heartbeat) and atrial flutter
150 mg 4 pills
-
93 3129 93 3129
Disopyramide Phosphate 150 mg
Brown & red, capsule, 19 mm
Used for atrial fibrillation (irregular heartbeat) and atrial flutter
- SEARLE 2742 NORPACE CR 150 MG Disopyramide Phosphate 150 mg Brown & green, capsule, 19 mm Used for atrial fibrillation (irregular heartbeat) and atrial flutter
- m 096 Disopyramide Phosphate 150 mg Brown, capsule, 19 mm Used for atrial fibrillation (irregular heartbeat) and atrial flutter
- SEARLE 2762 NORPACE 150 MG Disopyramide Phosphate 150 mg Brown & orange, capsule, 19 mm Used for atrial fibrillation (irregular heartbeat) and atrial flutter
Other 1 pill
What is Disopyramide Phosphate used for?
Disopyramide Phosphate is used for atrial fibrillation (irregular heartbeat), atrial flutter and ventricular premature complexes.
- Medicine type
- Heart rhythm medicine
Official uses from the US prescribing label
Norpace and Norpace CR are indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening. Because of the proarrhythmic effects of Norpace and Norpace CR, their use with lesser arrhythmias is generally not recommended. Treatment of patients with asymptomatic ventricular premature contractions should be avoided.
Initiation of Norpace or Norpace CR treatment, as with other antiarrhythmic agents used to treat life-threatening arrhythmias, should be carried out in the hospital. Norpace CR should not be used initially if rapid establishment of disopyramide plasma levels is desired.
Antiarrhythmic drugs have not been shown to enhance survival in patients with ventricular arrhythmias.
From the FDA-approved label on DailyMed (published Aug 25, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.